[30P-am363S] Investigation of drugs and underlying diseases affecting the development of HMG-CoA reductase inhibitor-induced rhabdomyolysis using the FDA Adverse Event Reporting System
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.